Synergistic Comprehensive Activation Methods for Dual‐Modality PDT and Hypoxia‐Triggered Chemotherapy Guided by NIR‐II Imaging beyond 1700 nm in Deep Tumors
Small · 2025
DOI: 10.1002/smll.202500553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Haoran Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Luminescence Science and Technology, Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences, …. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: autonomous project of SKLA, China Postdoctoral Science Foundation, Changchun Science and Technology Bureau.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Although photodynamic therapy (PDT) holds great promise for applications in cancer treatment, it has limited effectiveness against deep hypoxic tumors. Moreover, the lack of visualization guidance for precision theranostics poses additional challenges, hindering its broader clinical adoption. By combining NIR‐IIc (1800 nm) imaging guidance with internally and externally activatable dual‐modality PDT and hypoxia‐triggered chemotherapy, this study proposes a conceptual framework to overcome these limitations. This approach involves the use of photoswitchable lanthanide‐doped nanoparticles featuring Tm 3+ ‐activated upconversion/downshifting emissions coupled with carboxyl‐terminated Ir(III) complex‐based Type I/II photosensitizer to form a nanophotosensitizer. The findings demonstrate that this system enabled NIR‐IIc imaging guidance upon 808/980 nm excitation while selectively activating external PDT under 980 nm irradiation, thereby ensuring accurate therapy and minimizing phototoxicity risk. The Ir(III) complex conjugates with luminol to form a self‐illuminating Type I/II photosensitizer, which can respond to the elevated H 2 O 2 levels in the tumor microenvironment, effectively catalyzing chemiluminescence‐assisted PDT. Moreover, PDT aggravates tumor hypoxia, which in turn activates the hypoxia‐activatable prodrugs like tirapazamine, resulting in a synergistic antitumor effect. With NIR‐IIc imaging‐guided dual‐modality PDT, this study introduces a groundbreaking approach that unites Type I/II PDT with chemotherapy, significantly advancing the precise and effective treatment of deep hypoxic tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Luminescence Science and Technology, Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences, Changchun, 130033, P. R. China.
- School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road Shenhe District, Shenyang, Liaoning, 110016, P. R. China.
- Department of Respiratory Medicine, the First Hospital of Jilin University, Changchun, 130021, P. R. China.
ORCID-Profile: Yulei Chang
Förderung
- autonomous project of SKLA
- China Postdoctoral Science Foundation
- Changchun Science and Technology Bureau
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Project of Science and Technology Agency, Jilin Province
Zitieren
APA
Chen, H., Liu, S., Wang, W., Long, F., Li, Q., Gan, D., Li, X., Li, B., Kong, X., Li, D., & Chang, Y. (2025). Synergistic Comprehensive Activation Methods for Dual‐Modality PDT and Hypoxia‐Triggered Chemotherapy Guided by NIR‐II Imaging beyond 1700 nm in Deep Tumors. Small. https://doi.org/10.1002/smll.202500553
Vancouver
Chen H, Liu S, Wang W, Long F, Li Q, Gan D, et al. Synergistic Comprehensive Activation Methods for Dual‐Modality PDT and Hypoxia‐Triggered Chemotherapy Guided by NIR‐II Imaging beyond 1700 nm in Deep Tumors. Small. 2025. doi:10.1002/smll.202500553
BibTeX
@article{Chen2025,
author = {Chen, Haoran and Liu, Shengnan and Wang, Wang and Long, Fei and Li, Qiqing and Gan, Dechao and Li, Xiaodan and Li, Bin and Kong, Xianggui and Li, Dabing and Chang, Yulei},
title = {Synergistic Comprehensive Activation Methods for Dual‐Modality PDT and Hypoxia‐Triggered Chemotherapy Guided by NIR‐II Imaging beyond 1700 nm in Deep Tumors},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202500553}
}
EUVIMED